2024-11-07 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**Company Overview:** Intuitive Surgical Inc. (ISRG) is a leading manufacturer and provider of robotic-assisted surgical systems.

**1. Performance vs. S&P 500 (VOO):**

* **Cumulative return:** ISRG (371.43%) significantly outperformed VOO (139.88%).
* **Outperformance:** The current outperformance is 231.55%, placing it in the 79.86th percentile of historical outperformance relative to VOO.
* **Alpha & Beta Analysis:**  
    * ISRG consistently demonstrates high alpha and beta values, indicating strong performance relative to the market and high sensitivity to overall market movements. 
    * Notably, the beta values tend to hover around 1.2, suggesting that ISRG is slightly more volatile than the overall market.
    * The recent years show a slight decrease in Alpha, suggesting that the outperformance might be moderating, but still remains strong.

**2. Recent Price Action:**

* **Closing Price:** 515.55
* **5-day Moving Average:** 509.66
* **20-day Moving Average:** 503.36
* **60-day Moving Average:** 490.43
* **Analysis:** The current price is above all three moving averages, indicating an upward trend. The distance between the closing price and the moving averages suggests a potential continuation of the upward trend.

**3. Technical Indicators:**

* **RSI:** 73.95 -  Suggests that the stock is currently in overbought territory, indicating potential for a short-term correction. 
* **PPO:** -0.0 - Indicates that the stock's momentum is neutral.
* **Delta_Previous_Relative_Divergence:** +4.3 (20-day) -  This indicates a positive divergence, suggesting that the stock's price is moving higher while its momentum indicator is showing a slight upward trend.
* **Expected Return:** 12.59% -  This indicates that ISRG is projected to outperform the S&P 500 by 12.59% over the long term (2+ years) if a long-term investment strategy is adopted.

**4. Recent Earnings and Outlook:**

* **Earnings:**
    | Date       | EPS   | Revenue   |
    |-----------|-------|-----------|
    | 2024-10-18 | 1.59  | $2.04B |
    | 2024-07-19 | 1.48  | $2.01B |
    | 2024-04-19 | 1.54  | $1.89B |
    | 2023-10-20 | 1.18  | $1.74B |
    | 2024-10-18 | 1.18  | $1.74B |

* **Analysis:**  ISRG consistently beats earnings expectations. The most recent quarter showed revenue growth of 17.24% year-over-year.  

**5. Financial Information:**

* **Revenue and Profitability:**  ISRG consistently demonstrates strong revenue growth and profitability, with a high profit margin and sustained growth in both revenue and profit. 
* **Capital and Profitability:** The company maintains a robust equity position and healthy return on equity (ROE), indicating strong financial health. 

**6. News & Recent Issues:**

* **Earnings News:** Recent earnings releases have been well-received by analysts and investors, highlighting ISRG's continued growth and strong financial performance. 
* **Market Outlook:**  Analysts generally maintain a positive outlook for ISRG, citing continued growth in the robotic surgery market and the company's strong market position.
* **Analyst Opinions:**  Finbold and other financial news sources report a high percentage of analysts recommending a "buy" or "strong buy" rating for ISRG.

**7. Summary:**

ISRG has consistently outperformed the market, demonstrating strong profitability, robust financial health, and a positive outlook for the future. The stock is currently in overbought territory, indicating potential for a short-term correction. However, the long-term prospects for the company remain strong, suggesting that it could continue to be a profitable investment for long-term investors. 

**Disclaimer:** This is not financial advice. It is important to conduct your own research and consult with a financial advisor before making any investment decisions. 
